MicroRNA 132 Regulates Nutritional Stress-Induced Chemokine Production through Repression of SirT1

Por Strum, Jay C., Johnson, Jennifer H., Ward, James, Xie, Hongbo, Feild, John, Hester, Austin, Alford, Alexander, Waters, K. Michelle
Publicado no Mol Endocrinol (2009)

Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors

Por Bisi, John E., Sorrentino, Jessica A., Jordan, Jamie L., Darr, David D., Roberts, Patrick J., Tavares, Francis X., Strum, Jay C.
Publicado no Oncotarget (2017)

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats

Por Yang, Baichun, Brown, Kathleen K, Chen, Lihong, Carrick, Kevin M, Clifton, Lisa G, McNulty, Judi A, Winegar, Deborah A, Strum, Jay C, Stimpson, Stephen A, Pahel, Gregory L
Publicado em 2004

Multiple Roles of Cyclin-Dependent Kinase 4/6 Inhibitors in Cancer Therapy

Por Roberts, Patrick J., Bisi, John E., Strum, Jay C., Combest, Austin J., Darr, David B., Usary, Jerry E., Zamboni, William C., Wong, Kwok-Kin, Perou, Charles M., Sharpless, Norman E.
Publicado em 2012

Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion

Por He, Shenghui, Roberts, Patrick J., Sorrentino, Jessica A., Bisi, John E., Storrie-White, Hannah, Tiessen, Renger G., Makhuli, Karenann M., Wargin, William A., Tadema, Henko, van Hoogdalem, Ewoud-Jan, Strum, Jay C., Malik, Rajesh, Sharpless, Norman E.
Publicado no Sci Transl Med (2017)

Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 Adipocytes

Por Rong, James X., Klein, Jean-Louis D., Qiu, Yang, Xie, Mi, Johnson, Jennifer H., Waters, K. Michelle, Zhang, Vivian, Kashatus, Jennifer A., Remlinger, Katja S., Bing, Nan, Crosby, Renae M., Jackson, Tymissha K., Witherspoon, Sam M., Moore, John T., Ryan, Terence E., Neill, Sue D., Strum, Jay C.
Publicado em 2011

CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation

Por Deng, Jiehui, Wang, Eric S., Jenkins, Russell W., Li, Shuai, Dries, Ruben, Yates, Kathleen, Chhabra, Sandeep, Huang, Wei, Liu, Hongye, Aref, Amir R., Ivanova, Elena, Paweletz, Cloud P., Bowden, Michaela, Zhou, Chensheng W., Herter-Sprie, Grit S., Sorrentino, Jessica A., Bisi, John E, Lizotte, Patrick H., Merlino, Ashley A., Quinn, Max M., Bufe, Lauren E., Yang, Annan, Zhang, Yanxi, Zhang, Hua, Gao, Peng, Chen, Ting, Cavanaugh, Megan E., Rode, Amanda J., Haines, Eric, Roberts, Patrick J., Strum, Jay C, Richards, William G., Lorch, Jochen H., Parangi, Sareh, Gunda, Viswanath, Boland, Genevieve M., Bueno, Raphael, Palakurthi, Sangeetha, Freeman, Gordon J, Ritz, Jerome, Haining, W. Nicholas, Sharpless, Norman E., Arthanari, Haribabu, Shapiro, Geoffrey I., Barbie, David A., Gray, Nathanael S., Wong, Kwok-Kin
Publicado no Cancer Discov (2017)